We are live on ! Find out more
ABBV icon

AbbVie
ABBV

1,287 hedge funds and large institutions have $44.6B invested in AbbVie in 2013 Q2 according to their latest regulatory filings, with 1,287 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68.14% more ownership

Funds ownership: 0% → 68.14% (+68%)

32% more call options, than puts

Call options by funds: $187M | Put options by funds: $142M

Holders
1,287
Holders Change
+1,287
Holders Change %
–
% of All Funds
41.85%
Holding in Top 10
39
Holding in Top 10 Change
+39
Holding in Top 10 Change %
% of All Funds
1.27%
New
1,287
Increased
–
Reduced
–
Closed
–
Calls
$187M
Puts
$142M
Net Calls
+$44.8M
Net Calls Change
+$44.8M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ABBV Hedge Fund Activity: Q2 2013 in Review

1,287 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q2 2013, worth a combined $44.6B.

Buyers outnumbered sellers: 1,287 funds opened new ABBV positions and 0 closed out — a net gain of 1,287 holders — while 0 added to existing stakes and 0 trimmed.

  • 1,287 institutional investors held AbbVie (ABBV) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $44.6B of AbbVie stock for Q2 2013.
  • 1,287 funds opened new AbbVie positions in Q2 2013 and 0 closed out, a net change of +1,287 holders.

Based on aggregated 13F filings for Q2 2013.